Drug Profile
Tc 99m adrenomedullin
Alternative Names: 99mTC-PulmoBind; DFH-12; PulmoBindLatest Information Update: 22 Aug 2019
Price :
$50
*
At a glance
- Originator Montreal Heart Institute; Pulmo BioTech
- Class Heavy metals; Peptide hormones; Radiopharmaceutical diagnostics; Transition elements
- Mechanism of Action
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported Pulmonary embolism; Pulmonary hypertension
Most Recent Events
- 22 Aug 2019 No development reported - Phase-II for Pulmonary embolism (Diagnosis, In volunteers) in Canada (IV)
- 22 Aug 2019 No development reported - Phase-II for Pulmonary hypertension (Diagnosis, In volunteers) in Canada (IV)
- 09 Jul 2008 PulmoScience completes preclinical biodistribution studies in the US